NASDAQ:ICPT - Intercept Pharmaceuticals Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $111.35 +2.01 (+1.84 %) (As of 03/26/2019 04:00 PM ET)Previous Close$109.34Today's Range$109.45 - $111.8852-Week Range$58.03 - $133.74Volume311,200 shsAverage Volume995,316 shsMarket Capitalization$3.31 billionP/E Ratio-10.19Dividend YieldN/ABeta1.62 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Intercept Pharmaceuticals (NASDAQ:ICPT) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.21 Wall Street analysts have issued ratings and price targets for Intercept Pharmaceuticals in the last 12 months. Their average twelve-month price target is $147.10, suggesting that the stock has a possible upside of 32.11%. The high price target for ICPT is $251.00 and the low price target for ICPT is $68.00. There are currently 2 sell ratings, 4 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.622.572.742.50Ratings Breakdown: 2 Sell Rating(s)4 Hold Rating(s)15 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)5 Hold Rating(s)14 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)5 Hold Rating(s)14 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)9 Hold Rating(s)9 Buy Rating(s)1 Strong Buy Rating(s)Consensus Price Target: $147.10$145.40$150.6875$131.2222Price Target Upside: 32.11% upside62.02% upside44.07% upside13.16% upsideIntercept Pharmaceuticals (NASDAQ:ICPT) Consensus Price Target History Intercept Pharmaceuticals (NASDAQ:ICPT) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails3/19/2019OppenheimerReiterated RatingBuyLow3/5/2019WedbushSet Price TargetBuy$251.00Medium3/1/2019Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$130.00High2/28/2019B. RileyReiterated RatingBuy ➝ Buy$155.00 ➝ $169.00High2/28/2019Raymond JamesSet Price TargetStrong-Buy ➝ Buy$184.00 ➝ $187.00High2/28/2019Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$170.00 ➝ $191.00High2/22/2019Svb LeerinkDowngradeMarket Perform ➝ Underperform$70.00Medium2/22/2019Leerink SwannDowngradeOutperform ➝ Market Perform$70.00Medium2/21/2019CitigroupBoost Price TargetNeutral ➝ Neutral$106.00 ➝ $140.00High2/20/2019JMP SecuritiesBoost Price TargetOutperform ➝ In-Line$175.00 ➝ $200.00High2/19/2019Wells Fargo & CoBoost Price TargetMarket Perform$75.00 ➝ $127.00High2/15/2019Bank of AmericaReiterated RatingUnderperform$68.00Low2/12/2019Credit Suisse GroupReiterated RatingOutperformHigh1/28/2019Jefferies Financial GroupBoost Price TargetBuy$150.00Low1/24/2019Needham & Company LLCUpgradeHold ➝ Buy$150.00High1/23/2019UBS GroupInitiated CoverageBuy ➝ Buy$130.00Low1/14/2019LaidlawUpgradeHold ➝ Buy$99.00 ➝ $130.00Low11/19/2018CIBCUpgradeMarket Perform ➝ OutperformMedium9/12/2018Roth CapitalInitiated CoverageBuy ➝ Buy$192.00Low8/6/2018Goldman Sachs GroupUpgradeSell ➝ Buy$46.00 ➝ $157.00High5/9/2018CowenReiterated RatingBuy$88.00Low2/15/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$152.00 ➝ $155.00High2/12/2018Deutsche BankInitiated CoverageBuy$103.00Medium1/25/2018Robert W. BairdReiterated RatingOutperform$332.00 ➝ $253.00Low10/6/2017Seaport Global SecuritiesReiterated RatingBuy$136.00N/A9/22/2017Morgan StanleyReiterated RatingUnderweight$75.00 ➝ $50.00High(Data available from 3/26/2017 forward) This page was last updated on 3/26/2019 by MarketBeat.com StaffFeatured Article: How is a buy-side analyst different from a sell-side analyst?